Cargando…
O-3 Clinical features and outcome measures during 1 year enzyme replacement therapy in late onset GSD II patients
Autores principales: | Angelini, C., Semplicini, C., Pegoraro, E., Filosto, M., Marrosu, G., Piras, R., Mongini, T., Vercelli, L., Tonin, P., Servidei, S., Di Giacopo, R., Crescimanno, G., Ravaglia, S., Toscano, A., Musumeci, O., Siciliano, G., Ricci, G., Di Iorio, Cipullo, F., Moggio, M., Comi, G., Lucchini, V., Morandi, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SpA
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235874/ |
Ejemplares similares
-
I-4
Long-term follow-up effects on enzyme
replacement treatment of adult form of acid
maltase deficiency myopathy
por: Angelini, C., et al.
Publicado: (2011) -
Evaluation of muscle biopsy in late-onset GSDII patients before and after enzyme replacement therapy (ERT)
por: Violano, R, et al.
Publicado: (2013) -
Genotype-phenotype correlation in Pompe disease, a step forward
por: De Filippi, Paola, et al.
Publicado: (2014) -
Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases
por: Mancuso, M., et al.
Publicado: (2012) -
Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients
por: Musumeci, Olimpia, et al.
Publicado: (2019)